These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2866051)

  • 61. [Clinical studies on autoimmune mechanisms of the thyroid Part II. Leucocyte migration inhibiton studies in Hashimoto's thyroiditis and in Graves' disease (author's transol)].
    Ikekubo K
    Nihon Naibunpi Gakkai Zasshi; 1975 Oct; 51(10):840-55. PubMed ID: 1243915
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [A study using FRTL-5 cell for detecting thyroid stimulating antibody activity in serum in patients with Graves disease].
    Li J; Gao H; Jin SX
    Zhonghua Nei Ke Za Zhi; 1991 Jul; 30(7):392-4, 454. PubMed ID: 1684315
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease.
    Ginsberg J; von Westarp C
    CMAJ; 1986 May; 134(10):1141-7. PubMed ID: 2421862
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods.
    Morris JC; Hay ID; Nelson RE; Jiang NS
    Mayo Clin Proc; 1988 Jul; 63(7):707-17. PubMed ID: 2898572
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Relationship of eye muscle antibodies with HLA phenotypes and thyroid-stimulating immunoglobulins in endocrine orbitopathy.
    Kahaly G; Moncayo R; Stover C; Beyer J
    Res Exp Med (Berl); 1991; 191(2):137-44. PubMed ID: 1677484
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Coexistence of thyroid-stimulating and thyroid-blocking antibodies in a patient with Graves' disease who had transient hypothyroidism.
    Miyauchi A; Amino N; Tamaki H; Kuma K
    Am J Med; 1988 Sep; 85(3):418-20. PubMed ID: 2901227
    [No Abstract]   [Full Text] [Related]  

  • 67. Detectability of antibodies directed against different thyroid structures by indirect immunofluorescence, with Graves' patients' sera. A prospective study.
    Szabo J; Forizs E; Bako G; Mezösi E; Leövey A
    Radiobiol Radiother (Berl); 1987; 28(5):590-5. PubMed ID: 2894708
    [No Abstract]   [Full Text] [Related]  

  • 68. An investigation of pedigrees of 110 patients with Graves' disease and the clinical significance of determinations of antithyroid antibodies of their first-degree relatives.
    Wang DQ; Wang JZ; Ren JM; Zhou XT; Peng WC
    Chin Med J (Engl); 1994 Nov; 107(11):817-21. PubMed ID: 7867387
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison between thyroid stimulating and tsh-binding inhibiting immunoglobulins of Graves' disease.
    Macchia E; Fenzi GF; Monzani F; Lippi F; Vitti P; Grasso L; Bartalena L; Baschieri L; Pinchera A
    Clin Endocrinol (Oxf); 1981 Aug; 15(2):175-82. PubMed ID: 6118213
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Immune mechanisms in Graves' disease.
    Burman KD; Baker JR
    Endocr Rev; 1985; 6(2):183-232. PubMed ID: 2988930
    [No Abstract]   [Full Text] [Related]  

  • 71. T cell subsets and thyroid-stimulating antibodies in patients with Graves' disease in clinical remission.
    Bagnasco M; Macchia E; Ciprandi G; Caria M; Fenzi GF
    J Endocrinol Invest; 1986 Jun; 9(3):217-21. PubMed ID: 2876022
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Measurements by competitive binding radioassay of serum anti-microsomal and anti-thyroglobulin antibodies in Graves' disease and other thyroid disorders.
    Mori T; Kriss JP
    J Clin Endocrinol Metab; 1971 Oct; 33(4):688-98. PubMed ID: 5109861
    [No Abstract]   [Full Text] [Related]  

  • 73. UCLA conference. Autoimmune thyroid diseases--Graves' and Hashimoto's.
    Ann Intern Med; 1978 Mar; 88(3):379-91. PubMed ID: 204241
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The thyroid-stimulating antibody of Graves' disease: evidence for restricted heterogeneity.
    Zakarija M
    Horm Res; 1980; 13(1):1-15. PubMed ID: 6777285
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Kappa/lambda immunoglobulin distribution in Graves' thyroid-stimulating antibodies. Simultaneous analysis of C lambda gene polymorphisms.
    Williams RC; Marshall NJ; Kilpatrick K; Montano J; Brickell PM; Goodall M; Ealey PA; Shine B; Weetman AP; Craig RK
    J Clin Invest; 1988 Oct; 82(4):1306-12. PubMed ID: 2902107
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Graves' disease in pregnancy: TSH receptor binding inhibiting immunoglobulins and maternal and neonatal thyroid function.
    Mortimer RH; Tyack SA; Galligan JP; Perry-Keene DA; Tan YM
    Clin Endocrinol (Oxf); 1990 Feb; 32(2):141-52. PubMed ID: 1971773
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antibody to gp39, the ligand for CD40 significantly inhibits the humoral response from Graves' thyroid tissues xenografted into severe combined immunodeficient (SCID) mice.
    Resetkova E; Kawai K; Enomoto T; Arreaza G; Togun R; Foy TM; Noelle RJ; Volpé R
    Thyroid; 1996 Aug; 6(4):267-73. PubMed ID: 8875745
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human lymphocyte antigens (HLA) and Graves' disease in Turkey.
    Orhan Y; Azezli A; Carin M; Aral F; Sencer E; Molvalilar S
    J Clin Immunol; 1993 Sep; 13(5):339-43. PubMed ID: 7902362
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Thyroid microsomal antigen in Graves' thyroid is not different from that in normal thyroid.
    Hamada N; Degroot LJ; Portmann L; Yamakawa J; Noh J; Okamoto Y; Ohno M; Ito K; Morii H
    Endocrinol Jpn; 1991 Oct; 38(5):471-8. PubMed ID: 1843266
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Introduction to the etiology and pathogenesis of autoimmune forms of thyroid diseases].
    Teuber J; Federlin K
    Immun Infekt; 1983 Nov; 11(6):209-19. PubMed ID: 6689624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.